Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Italy Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20082
20104
20111
20132
20142
20153
20164
20177
20185
20203
20213
20223
20231
20241
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting10
Terminated9
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
AbbVie3
Astellas Pharma Global Development, Inc.3
Astex Pharmaceuticals, Inc.3
Daiichi Sankyo3
Celgene2
Gilead Sciences2
Novartis Pharmaceuticals2
Pfizer2
Stichting Hemato-Oncologie voor Volwassenen Nederland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute54
Leukemia10
Myelodysplastic Syndromes7
Leukemia, Myelomonocytic, Chronic4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Leukemia, Erythroblastic, Acute3
Leukemia, Megakaryoblastic, Acute3
Leukemia, Monocytic, Acute3
Leukemia, Myelomonocytic, Acute3

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.